Fundz

Neuroelectrics, Inc. reported raising $17.9 Million in an initial SEC Form D filing

PRIVATENov 19, 2020

Amount Raised

$17.9 Million

$17.9 Million sold, per SEC Form D (first sale Nov 19, 2020)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Neuroelectrics, Inc. raised $17.9 Million in a funding round, dated November 19, 2020. Neuroelectrics, Inc. is based in Cambridge, Maryland, United States.

How much did Neuroelectrics, Inc. raise?
Neuroelectrics, Inc. raised $17.9 Million in a funding round on November 19, 2020.
What does Neuroelectrics, Inc. do?
Neuroelectrics is developing a therapeutic platform that uses neuromodulation for the treatment of a range of neurological and psychiatric disorders.
Where is Neuroelectrics, Inc. based and how big is it?
Neuroelectrics, Inc. is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neuroelectrics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CYTIMMUNE SCIENCES INC raised $998K (Seed) on December 31, 2020.
  • LeafWorks Inc. raised $679K (Seed) on December 30, 2020.
  • NUTRALIFE BIOSCIENCES, INC raised $25K (Seed) on December 30, 2020.
  • Celtic Renewables raised $2.2M on December 30, 2020.
  • Akston raised $3.4M (Seed) on December 30, 2020.
  • Peptilogics raised $36M on December 30, 2020.

Who to call at Neuroelectrics, Inc., and when

A new round usually means Neuroelectrics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neuroelectrics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neuroelectrics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neuroelectrics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neuroelectrics, Inc.

Location

210 BROADWAY, SUITE 201

Cambridge, Maryland, United States

About

Neuroelectrics is developing a therapeutic platform that uses neuromodulation for the treatment of a range of neurological and psychiatric disorders. The platform combines safe and proven neuromodulation capabilities with remote-controlled delivery and personalized treatment protocols to restore and maintain brain health. Based in Cambridge, Massachusetts and Barcelona, Neuroelectrics has an expanding pipeline of computationally driven solutions for neurologic and psychiatric disease. Visit www.neuroelectrics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neuroelectrics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neuroelectrics, Inc.'s next move

See what Strategic adds

Neuroelectrics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.